These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 16328537)

  • 41. Late-Onset Bartter Syndrome Type II Due to a Homozygous Mutation in KCNJ1 Gene: A Case Report and Literature Review.
    Elfert KA; Geller DS; Nelson-Williams C; Lifton RP; Al-Malki H; Nauman A
    Am J Case Rep; 2020 Sep; 21():e924527. PubMed ID: 32997650
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Adult presentation of Bartter syndrome type IV with erythrocytosis.
    Heilberg IP; Tótoli C; Calado JT
    Einstein (Sao Paulo); 2015; 13(4):604-6. PubMed ID: 26537508
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Mutations in the chloride channel gene, CLCNKB, leading to a mixed Bartter-Gitelman phenotype.
    Jeck N; Konrad M; Peters M; Weber S; Bonzel KE; Seyberth HW
    Pediatr Res; 2000 Dec; 48(6):754-8. PubMed ID: 11102542
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Barttin mutations in antenatal Bartter syndrome with sensorineural deafness.
    Ozlu F; Yapicioğlu H; Satar M; Narli N; Ozcan K; Buyukcelik M; Konrad M; Demirhan O
    Pediatr Nephrol; 2006 Jul; 21(7):1056-7. PubMed ID: 16773427
    [No Abstract]   [Full Text] [Related]  

  • 45. [Bartter's syndrome].
    Daniluk U; Kaczmarski M; Wasilewska J; Matuszewska E; Semeniuk J; Sidor K; Krasnow A
    Pol Merkur Lekarski; 2004 May; 16(95):484-9. PubMed ID: 15518434
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Bartter syndrome type III with only a synonymous mutation of the
    Xue Y; Wang B; Tang R; Ni H; Chen P; Liu BC; Zhang X
    Clin Nephrol; 2019 Dec; 92(6):325-328. PubMed ID: 31661060
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Nephrocalcinosis as adult presentation of Bartter syndrome type II.
    Huang L; Luiken GP; van Riemsdijk IC; Petrij F; Zandbergen AA; Dees A
    Neth J Med; 2014 Feb; 72(2):91-3. PubMed ID: 24659592
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A novel CLCNKB variant in a Chinese family with classic Bartter syndrome and prenatal genetic diagnosis.
    Zhao Q; Xiang Q; Tan Y; Xiao X; Xie H; Wang H; Yang M; Liu S
    Mol Genet Genomic Med; 2022 Oct; 10(10):e2027. PubMed ID: 35913199
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Clinical and Genetic Spectrum of Bartter Syndrome Type 3.
    Seys E; Andrini O; Keck M; Mansour-Hendili L; Courand PY; Simian C; Deschenes G; Kwon T; Bertholet-Thomas A; Bobrie G; Borde JS; Bourdat-Michel G; Decramer S; Cailliez M; Krug P; Cozette P; Delbet JD; Dubourg L; Chaveau D; Fila M; Jourde-Chiche N; Knebelmann B; Lavocat MP; Lemoine S; Djeddi D; Llanas B; Louillet F; Merieau E; Mileva M; Mota-Vieira L; Mousson C; Nobili F; Novo R; Roussey-Kesler G; Vrillon I; Walsh SB; Teulon J; Blanchard A; Vargas-Poussou R
    J Am Soc Nephrol; 2017 Aug; 28(8):2540-2552. PubMed ID: 28381550
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Co-Existence of Congenital Adrenal Hyperplasia and Bartter Syndrome due to Maternal Uniparental Isodisomy of HSD3B2 and CLCNKB Mutations.
    Giri D; Bockenhauer D; Deshpande C; Achermann JC; Taylor NF; Rumsby G; Morgan H; Senniappan S; Ajzensztejn M
    Horm Res Paediatr; 2020; 93(2):137-142. PubMed ID: 32506065
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Molecular analysis of patients with type III Bartter syndrome: picking up large heterozygous deletions with semiquantitative PCR.
    Nozu K; Fu XJ; Nakanishi K; Yoshikawa N; Kaito H; Kanda K; Krol RP; Miyashita R; Kamitsuji H; Kanda S; Hayashi Y; Satomura K; Shimizu N; Iijima K; Matsuo M
    Pediatr Res; 2007 Sep; 62(3):364-9. PubMed ID: 17622951
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Identification and functional analysis of novel mutations of the CLCNKB gene in Chinese patients with classic Bartter syndrome.
    Yu Y; Xu C; Pan X; Ren H; Wang W; Meng X; Huang F; Chen N
    Clin Genet; 2010 Feb; 77(2):155-62. PubMed ID: 19807735
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Novel mutations of the chloride channel Kb gene in two Japanese patients clinically diagnosed as Bartter syndrome with hypocalciuria.
    Fukuyama S; Hiramatsu M; Akagi M; Higa M; Ohta T
    J Clin Endocrinol Metab; 2004 Nov; 89(11):5847-50. PubMed ID: 15531551
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Salt wasting and deafness resulting from mutations in two chloride channels.
    Schlingmann KP; Konrad M; Jeck N; Waldegger P; Reinalter SC; Holder M; Seyberth HW; Waldegger S
    N Engl J Med; 2004 Mar; 350(13):1314-9. PubMed ID: 15044642
    [No Abstract]   [Full Text] [Related]  

  • 55. Transient neonatal hyperkalemia in the antenatal (ROMK defective) Bartter syndrome.
    Finer G; Shalev H; Birk OS; Galron D; Jeck N; Sinai-Treiman L; Landau D
    J Pediatr; 2003 Mar; 142(3):318-23. PubMed ID: 12640382
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Endocochlear potential depends on Cl- channels: mechanism underlying deafness in Bartter syndrome IV.
    Rickheit G; Maier H; Strenzke N; Andreescu CE; De Zeeuw CI; Muenscher A; Zdebik AA; Jentsch TJ
    EMBO J; 2008 Nov; 27(21):2907-17. PubMed ID: 18833191
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Infantile variant of Bartter syndrome and sensorineural deafness: a new autosomal recessive disorder.
    Landau D; Shalev H; Ohaly M; Carmi R
    Am J Med Genet; 1995 Dec; 59(4):454-9. PubMed ID: 8585565
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Generation and analyses of R8L barttin knockin mouse.
    Nomura N; Tajima M; Sugawara N; Morimoto T; Kondo Y; Ohno M; Uchida K; Mutig K; Bachmann S; Soleimani M; Ohta E; Ohta A; Sohara E; Okado T; Rai T; Jentsch TJ; Sasaki S; Uchida S
    Am J Physiol Renal Physiol; 2011 Aug; 301(2):F297-307. PubMed ID: 21593186
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Genetic basis of Bartter syndrome in Korea.
    Lee BH; Cho HY; Lee H; Han KH; Kang HG; Ha IS; Lee JH; Park YS; Shin JI; Lee DY; Kim SY; Choi Y; Cheong HI
    Nephrol Dial Transplant; 2012 Apr; 27(4):1516-21. PubMed ID: 21865213
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A novel compound heterozygous ROMK mutation presenting as late onset Bartter syndrome associated with nephrocalcinosis and elevated 1,25(OH)(2) vitamin D levels.
    Sharma A; Linshaw MA
    Clin Exp Nephrol; 2011 Aug; 15(4):572-6. PubMed ID: 21431899
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.